Differences in hormonal levels between heterozygous CYP21A2 pathogenic variant carriers, non-carriers, and females with non-classic congenital hyperplasia (original) (raw)

Phenotypic variability of hyperandrogenemia in females heterozygous for CYP21A2 mutations

Vassos Neocleous, Leonidas Phylactou, Nicos Skordis

Indian Journal of Endocrinology and Metabolism, 2014

View PDFchevron_right

Research Article Variations in the 3′UTR of the CYP21A2 Gene in Heterozygous Females with Hyperandrogenaemia

Vassos Neocleous, Meropi Toumba

View PDFchevron_right

CYP21A2 Genotypes do not Predict the Severity of Hyperandrogenic Manifestations in the Nonclassical Form of Congenital Adrenal Hyperplasia

Berenice Mendonca

Hormone and Metabolic Research, 2013

View PDFchevron_right

Variations in the 3′UTR of theCYP21A2Gene in Heterozygous Females with Hyperandrogenaemia

Nicos Skordis

International Journal of Endocrinology, 2017

View PDFchevron_right

Novel Mutations in CYP21 Detected in Individuals with Hyperandrogenism

Hélène Blanché

The Journal of Clinical Endocrinology & Metabolism, 2002

View PDFchevron_right

Common Genetic Variants of the Human Steroid 21- Hydroxylase Gene (CYP21A2) Are Related to Differences in Circulating Hormone Levels

Klara Koncz, Marton Doleschall

View PDFchevron_right

Adrenal 21-hydroxylase gene mutations in Slovenian hyperandrogenic women: evaluation of corticotrophin stimulation and HLA polymorphisms in screening for carrier status

Vita Dolzan

European Journal of Endocrinology, 1999

View PDFchevron_right

Genetic analysis does not confirm non-classical congenital adrenal hyperplasia in more than a third of the women followed with this diagnosis

Rosa Corcoy

HORMONES, 2014

View PDFchevron_right

Phenotype and genotype correlation of the microconversion from the CYP21A1P to the CYP21A2 gene in congenital adrenal hyperplasia

Lucila Leico Kagohara Elias

Brazilian Journal of Medical and Biological Research, 2003

View PDFchevron_right

The spectrum of clinical, hormonal and molecular findings in 280 individuals with nonclassical congenital adrenal hyperplasia caused by mutations of the CYP21A2 gene

Amalia Sertedaki

Clinical endocrinology, 2015

View PDFchevron_right

Relationship of CYP21A2 genotype and serum 17-hydroxyprogesterone and cortisol levels in a large cohort of Italian children with premature pubarche

Daniela Carta

European Journal of Endocrinology, 2011

View PDFchevron_right

Genotyping of CYP21, Linked Chromosome 6p Markers, and a Sex-Specific Gene in Neonatal Screening for Congenital Adrenal Hyperplasia*

Phyllis W Speiser

2010

View PDFchevron_right

Genetic screening of non-classic CAH females with hyperandrogenemia identifies a novel CYP11B1 gene mutation

Vassos Neocleous

View PDFchevron_right

Genotyping of CYP21, Linked Chromosome 6p Markers, and a Sex-Specific Gene in Neonatal Screening for Congenital Adrenal Hyperplasia 1

Phyllis Speiser

The Journal of Clinical Endocrinology & Metabolism, 1999

View PDFchevron_right

Genetic defects of the CYP21A2 gene in girls with premature adrenarche

Nicos Skordis

Journal of Endocrinological Investigation, 2014

View PDFchevron_right

Compound heterozygosity for a whole gene deletion and p.R124C mutation in CYP21A2 causing nonclassic congenital adrenal hyperplasia

Hamza Nasir

Annals of pediatric endocrinology & metabolism, 2018

View PDFchevron_right

A p.P30L Mutation at the CYP21A2 Gene in Macedonian Patients with Nonclassical Congenital Adrenal Hyperplasia

Violeta Anastasovska

Balkan Journal of Medical Genetics, 2010

View PDFchevron_right

Prevalence of CYP21 mutations and IRS1 variant among women with polycystic ovary syndrome and adrenal androgen excess

Christopher Aston

Fertility and Sterility, 2005

View PDFchevron_right

Endocrine profile and phenotype-genotype correlation in unrelated patients with non-classical congenital adrenal hyperplasia

Leonidas Phylactou, Vassos Neocleous

Clinical Biochemistry, 2011

View PDFchevron_right

Mutations in the CYP21B gene in a Chilean population with simple virilizing congenital adrenal hyperplasia

Isabel Torrealba

Journal of Endocrinological Investigation, 2000

View PDFchevron_right

Clinical Role of CYP2C19 Polymorphisms in Patients with Congenital Adrenal Hyperplasia Due to 21-hydroxylase Deficiency

Tinka Hovnik

Acta Chimica Slovenica, 2016

View PDFchevron_right

Molecular CYP21A2 diagnosis in 480 Brazilian patients with congenital adrenal hyperplasia before newborn screening introduction

Paula Presti

European journal of endocrinology, 2016

View PDFchevron_right

The Frequency of Eight Common Point Mutations in CYP21 Gene in Iranian Patients with Congenital Adrenal Hyperplasia

Nejat Mahdieh

View PDFchevron_right

The presence of the 21-hydroxylase deficiency carrier status in hirsute women: phenotype-genotype correlations

Jose Sancho

Fertility and Sterility, 1999

View PDFchevron_right

Development of CYP21A2 Genotyping Assay for the Diagnosis of Congenital Adrenal Hyperplasia

Mayara Prado

Molecular diagnosis & therapy, 2017

View PDFchevron_right